Fennec Pharmaceuticals Inc.FENCNASDAQ
LOADING
|||
EPS Growth Accelerating
Trending higher, above historical average, modest growth trend.
Left:
||||
Year-over-year earnings per share growth rate
Latest
97.33%
↑ 488% above average
Average (9y)
-25.08%
Historical baseline
Range
High:97.33%
Low:-261.25%
CAGR
+3.4%
Modest growth trend
| Period | Value |
|---|---|
| 2024 | 97.33% |
| 2023 | 36.84% |
| 2022 | -41.79% |
| 2021 | 11.84% |
| 2020 | -20.63% |
| 2019 | -21.15% |
| 2018 | -10.64% |
| 2017 | -113.64% |
| 2016 | -261.25% |
| 2015 | 72.32% |